SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neptune Technologies & Bioressources Inc. - NTB.V
NEPT 0.200-45.9%Mar 6 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: The Ox who wrote (225)4/28/2014 10:22:41 AM
From: Sultan  Read Replies (1) of 902
 
Here we go.. May be we now get a CEO who can move the company to next level.. With activists and others stepping up, AGM just around the corner, some changes coming up here.

Neptune, Acasti and NeuroBioPharm Announce Resignation of Chief Executive Officer

LAVAL, Quebec, April 28, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") ( NEPT) ( NTB.TO), Acasti Pharma Inc. ("Acasti") ( ACST) ( APO.V) and NeuroBioPharm Inc. ("NeuroBio") today jointly announce the resignation of Henri Harland as President and Chief Executive Officer of Neptune, Acasti and NeuroBio with immediate effect. Mr. Harland remains a Director of Neptune, Acasti and NeuroBio. "I would like to thank Henri for his significant contributions as founder and executive of Neptune and its subsidiaries and wish him success in the future," said Dr. Ronald Denis, Chairman of Neptune.

The businesses will continue to be managed by a management and operations committee under the leadership of Neptune's Chief Financial Officer, Mr. Andre Godin. The search for a new President and Chief Executive Officer will commence immediately.

finance.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext